ArQule Inc: Premium Company Profile
Scope
Report Highlights
Reasons to Purchase
Table of Contents
- Overview - page 1
- Catalyst - page 1
- Summary - page 1
- Table of Contents - page 2
- Table of figures - page 3
- Table of tables - page 4
- Company Structure - page 5
- Company Overview and Key Facts - page 5
- Business Description - page 6
- Landmark Products and Services - page 6
- Activated Checkpoint Therapy (ACT) - page 6
- Landmark Products and Services - page 6
- History - page 8
- M&A History - page 9
- Camitro - page 9
- Cyclis Pharmaceuticals - page 9
- M&A History - page 9
- Locations and Subsidiaries - page 11
- Company Financials - page 12
- Stock Market Performance - page 12
- P&L - page 13
- Balance Sheet - page 16
- Cash Flow - page 16
- Business Segment Performance - page 17
- Products & Services - page 18
- Pipeline Products - page 18
- In-house Pipeline - page 18
- ARQ 197 - page 18
- Collaboration Pipeline - page 19
- ARQ 501 - page 19
- ARQ 171 - page 19
- In-house Pipeline - page 18
- AC Forecast Product Sales - page 20
- Pipeline Products - page 18
- Competitors and Strategic Business Relationships - page 21
- Key Competitors - page 21
- Key Clients - page 22
- Shareholding Structure - page 23
- Strategy - page 24
- Company View - page 24
- Corporate Strategy - page 26
- SWOT Analysis - page 27
- Overview - page 27
- Strengths - page 28
- Collaboration with Roche - page 28
- Weaknesses - page 29
- Unproven drug discovery platforms - page 29
- Opportunities - page 30
- Market for anti-cancer drugs - page 30
- Threats - page 31
- Lengthy and expensive regulatory process - page 31
- Competition - page 31
- Value Chain Analysis - page 32
- Overview - page 32
- Discovery and Product Development - page 33
- Scorecard - page 34
- Overview - page 34
- Scorecard Analysis - page 35
- Key Employees - page 36
- List of Key Employees - page 36
- Key Employee Biographies - page 37
- Stephen A Hill - page 37
- Patrick J Zenner - page 37
- Timothy C Barabe - page 38
- Ronald M Lindsay - page 38
- Michael D Loberg - page 39
- William G Messenger - page 39
- Nancy A Simonian - page 40
- Peter S Lawrence - page 40
- Nigel J Rulewski - page 41
- Thomas C K Chan - page 41
- Anthony S Messina - page 42
- Financial and Operational Overview - page 43
- Financial and Operational Overview - page 43
- APPENDIX - page 46
- Ask the analyst - page 46
- Datamonitor consulting - page 46
- Disclaimer - page 46
- List of Tables
- Table 1: ArQule - Key Facts - page 5
- Table 2: ArQule - Locations and Subsidiaries - page 11
- Table 3: ArQule - Year-End Share Price and Market Capitalization, 2002-2006 ($) - page 12
- Table 4: ArQule - Key Events Impacting Share Price Performance - page 12
- Table 5: ArQule - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 13
- Table 6: ArQule - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) - page 15
- Table 7: ArQule - Balance Sheet, 2002-2006 ($ Mn) - page 16
- Table 8: ArQule - Cash Flow, 2002-2006 ($ Mn) - page 16
- Table 9: ArQule - Revenue Breakdown by Division, 2002-2006 ($ Mn) - page 17
- Table 10: ArQule - In -House Products - page 18
- Table 11: ArQule - Collaboration Products - page 19
- Table 12: ArQule - Forecast Sales, 2006-2010 ($ Mn) - page 20
- Table 13: ArQule - Key Competitors - page 21
- Table 14: ArQule - Key Clients - page 22
- Table 15: ArQule - Key Shareholders - page 23
- Table 16: ArQule - SWOT Analysis Summary - page 27
- Table 17: ArQule - Value Chain Analysis - page 32
- Table 18: ArQule - Scorecard - page 34
- Table 19: ArQule - Key Employees - page 36
- Table 20: ArQule - Financial and Operational Overview - page 44
- List of Figures
- Figure 1: ArQule - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 14
Other users found this report page using the following search terms: structure 197 arq arqule chemical messina arq197 telephone s ion
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.